spacer
spacer

PDBsum entry 5cdy

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Oxidoreductase PDB id
5cdy

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
213 a.a.
Ligands
PO4
GOL ×2
Waters ×13
PDB id:
5cdy
Name: Oxidoreductase
Title: The crystal structure of 3-ketoacyl-(acyl-carrier-protein) reductase (fabg) from yersinia pestis at 2.85a resolution
Structure: 3-oxoacyl-[acyl-carrier protein] reductase. Chain: a, b, c, d. Synonym: 3-oxoacyl-[acyl-carrier-protein] reductase. Engineered: yes
Source: Yersinia pestis. Organism_taxid: 632. Gene: fabg, y1758, ypo1599. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.85Å     R-factor:   0.214     R-free:   0.246
Authors: J.D.Nanson,J.K.Forwood
Key ref: J.D.Nanson and J.K.Forwood (2015). Structural Characterisation of FabG from Yersinia pestis, a Key Component of Bacterial Fatty Acid Synthesis. Plos One, 10, e0141543. PubMed id: 26539719 DOI: 10.1371/journal.pone.0141543
Date:
06-Jul-15     Release date:   18-Nov-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
A0A5P8YI04  (A0A5P8YI04_YERPE) -  3-oxoacyl-[acyl-carrier-protein] reductase from Yersinia pestis
Seq:
Struc:
244 a.a.
213 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.1.1.1.100  - 3-oxoacyl-[acyl-carrier-protein] reductase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a (3R)-hydroxyacyl-[ACP] + NADP+ = a 3-oxoacyl-[ACP] + NADPH + H+
(3R)-hydroxyacyl-[ACP]
+ NADP(+)
= 3-oxoacyl-[ACP]
+ NADPH
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1371/journal.pone.0141543 Plos One 10:e0141543 (2015)
PubMed id: 26539719  
 
 
Structural Characterisation of FabG from Yersinia pestis, a Key Component of Bacterial Fatty Acid Synthesis.
J.D.Nanson, J.K.Forwood.
 
  ABSTRACT  
 
Ketoacyl-acyl carrier protein reductases (FabG) are ubiquitously expressed enzymes that catalyse the reduction of acyl carrier protein (ACP) linked thioesters within the bacterial type II fatty acid synthesis (FASII) pathway. The products of these enzymes, saturated and unsaturated fatty acids, are essential components of the bacterial cell envelope. The FASII reductase enoyl-ACP reductase (FabI) has been the focus of numerous drug discovery efforts, some of which have led to clinical trials, yet few studies have focused on FabG. Like FabI, FabG appears to be essential for survival in many bacteria, similarly indicating the potential of this enzyme as a drug target. FabG enzymes are members of the short-chain alcohol dehydrogenase/reductase (SDR) family, and like other SDRs, exhibit highly conserved secondary and tertiary structures, and contain a number of conserved sequence motifs. Here we describe the crystal structures of FabG from Yersinia pestis (YpFabG), the causative agent of bubonic, pneumonic, and septicaemic plague, and three human pandemics. Y. pestis remains endemic in many parts of North America, South America, Southeast Asia, and Africa, and a threat to human health. YpFabG shares a high degree of structural similarity with bacterial homologues, and the ketoreductase domain of the mammalian fatty acid synthase from both Homo sapiens and Sus scrofa. Structural characterisation of YpFabG, and comparison with other bacterial FabGs and the mammalian fatty acid synthase, provides a strong platform for virtual screening of potential inhibitors, rational drug design, and the development of new antimicrobial agents to combat Y. pestis infections.
 

 

spacer

spacer